# Beta-Blocker

Clinical effect of β-blocker overdose depends on underlying cardiac function, namely:

* Systolic function
* AV nodal blockade

# Disease


## Epidemiology and Risk Factors

## Pathophysiology

### Aetiology

## Clinical Manifestations

* Rate
	* Sinus bradycardia
	* Heart block\
	Full spectrum of AV nodal blockade, from 1^st^ degree heart block to CHB with no escape rhythm.
	* Asystole
* Hypotension
* Cardiogenic shock
	* Pulmonary oedema

## Diagnostic Approach and DDx

## Investigations

**Bedside**:

**Laboratory**:

**Imaging**:

**Other**:

## Management

**Resuscitation**:

* C
	* Bradycardia
		* Atropine\
		Reasonable for symptomatic bradycardia.
		* Adrenaline
		* Cardiac pacing
	* Hypotension
		* Volume resuscitation
		* Glucagon 10mg IV
		* High-dose insulin-euglycaemic therapy
		* Inotropes
		* Vasopressors
	* ECMO if refractory

:::column-margin
{{< include /includes/hiet.qmd >}}
:::

***Specific therapy**:

* Pharmacological
	* Activated charcoal
		* Within 1-hour of immediate release ingestion
		* Any time after sustained release ingestion
			* Consider multiple (Q4H) dosing
* Procedural
* Physical

**Supportive care**:

**Disposition**:

**Preventative**:


### Marginal and Ineffective Therapies

## Anaesthetic Considerations

## Complications

## Prognosis

## Key Studies


---

## References

1. Bersten, A. D., & Handy, J. M. (2018). Oh’s Intensive Care Manual. Elsevier Gezondheidszorg.
